Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CTO 1681 - CytoAgents

Next Previous
Drug Profile

CTO 1681 - CytoAgents

Alternative Names: CTO-1681; GP-1681-CytoAgents

Latest Information Update: 06 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CytoAgents
  • Class Antivirals; Eicosanoids; Small molecules
  • Mechanism of Action Cytokine inhibitors; G protein-coupled receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Cytokine release syndrome
  • No development reported COVID 2019 infections; Influenza virus infections

Most Recent Events

  • 24 Apr 2025 Adverse events data from a phase Ib/IIa trial in Cytokine release syndrome released by CytoAgents
  • 28 Jun 2024 No recent reports of development identified for preclinical development in Influenza-virus-infections in USA (PO)
  • 28 Nov 2023 No recent reports of development identified for phase-I development in COVID-2019-infections(In volunteers) in Australia (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top